Tocilizumab may be a potential addition to our weapons against neuro-Behcet's disease

被引：10

作者：

Borhani-Haghighi, Afshin ^{[1
]}

Safari, Anahid ^{[2
]}

机构：

[1] Shiraz Univ Med Sci, Nemazee Hosp, Dept Neurol, Shiraz, Iran

[2] Shiraz Univ Med Sci, Student Skill Lab, Shiraz, Iran

来源：

MEDICAL HYPOTHESES | 2008年 / 71卷 / 01期

关键词：

D O I：

10.1016/j.mehy.2008.01.011

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：156 / 157

页数：2

共 13 条

[1] A patient with neuro-Behcet's disease is successfully treated with etanercept:: Further evidence for the value of TNFα blockade [J].

Alty, Jane E. ;

Monaghan, Tanya M. ;

Bamford, John M. .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2007, 109 (03) :279-281

[2] Neuro-Behcet disease - A review [J].

Borhani-Haghighi, A ;

Pourmand, R ;

Nikseresht, AR .

NEUROLOGIST, 2005, 11 (02) :80-89

[3]

HAGHIGHI AB, CLIN NEUROL NEUROSUR, DOI DOI 10.1016/I.CLINEURO.2007.10.005

[4]

Hatachi Saori, 2006, Mod Rheumatol, V16, P321, DOI 10.1007/s10165-006-0507-1

[5] Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain [J].

Heyser, CJ ;

Masliah, E ;

Samimi, A ;

Campbell, IL ;

Gold, LH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1500-1505

[6] Cerebrospinal fluid interleukin-6 in progressive neuro-Behcet's syndrome [J].

Hirohata, S ;

Isshi, K ;

Oguchi, H ;

Ohse, T ;

Haraoka, H ;

Takeuchi, A ;

Hashimoto, T .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 82 (01) :12-17

[7] Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease [J].

Hirohata, S ;

Suda, H ;

Hashimoto, T .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 159 (02) :181-185

[8] Interleukin-6: discovery of a pleiotropic cytokine [J].

Kishimoto, Tadamitsu .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (Suppl 2)

[9] Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate [J].

Maini, R. N. ;

Taylor, P. C. ;

Szechinski, J. ;

Pavelka, K. ;

Broell, J. ;

Balint, G. ;

Emery, P. ;

Raemen, F. ;

Petersen, J. ;

Smolen, J. ;

Thomson, D. ;

Kishimoto, T. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2817-2829

[10]

Nakano Yuko, 2004, Seishin Shinkeigaku Zasshi, V106, P564

← 1 2 →